The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors

We determined the impact of bone marrow fibrosis (BMF) on the clinical outcomes of newly diagnosed multiple myeloma (NDMM) patients in the current era of myeloma therapy. A total of 393 MM patients were included in the final analysis. The median followup was 83 months (range: 3.9 to 212 months). BMF...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Barry, Zhao, Yue, Loitsch, Gavin, Feinberg, Daniel, Mathews, Parker, Barak, Ian, Dupuis, Megan, Li, Zhiguo, Rein, Lindsay, Wang, Endi, Kang, Yubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433821/
https://www.ncbi.nlm.nih.gov/pubmed/32628819
http://dx.doi.org/10.1002/cam4.3265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433821/
https://www.ncbi.nlm.nih.gov/pubmed/32628819
http://dx.doi.org/10.1002/cam4.3265

Ejemplares similares